Data & Analytics
Organizations are focusing on better ways to verify HCPs' digital identities.
Pfizer and Bristol-Myers Squibb were the top spenders last year.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.
How the retail pharmacy chain uses customer data to make its marketing messages relevant.
Deborah Furey will lead the agency's pilot of a new personalized marketing offering.
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
The first step is to seek leadership support, she says.
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
Most physicians said EHRs have negatively impacted their communication with a patients.
The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.
BMS and Pfizer outspent Johnson & Johnson two-to-one in advertising for their oral anticoagulant last year.
Judges praised Wunderman Health and GSK for their agility in reacting to dynamic information and creating segment-specific messaging for nasal spray allergy treatment Flonase.
A tracking poll conducted by the Kaiser Family Foundation also found that fewer Americans are seeing prescription drug ads compared to last year.
Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines
Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced AnalyticsSeptember 21, 2016
During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.
In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.
In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
A new government investigation found that most but not all prices for generic drugs dispensed by Medicare Part D fell from 2010 to 2015.
Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.
Jawbone data shows that people mentioning Pokémon Go in their comments have been walking 62.5% more than usual.
Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.
IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire
Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Five things for pharma marketers to know: Thursday, March 16, 2017
- Five things for pharma marketers to know: Tuesday, March 21, 2017
- Five things for pharma marketers to know: Friday, March 17, 2017